Quick Takeaways
- This page summarizes Robert E. Waltermire's Form 4 filing for MADRIGAL PHARMACEUTICALS, INC. (MDGL).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 17 Jan 2025, 19:08.
Robert E. Waltermire - 17 Jan 2025 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)
- Signature
- /s/ Mardi Dier, as Attorney-in-Fact
- Issuer symbol
- MDGL
- Transactions as of
- 17 Jan 2025
- Net transactions value
- -$120,847
- Form type
- 4
- Filing time
- 17 Jan 2025, 19:08:21 UTC
- Previous filing
- 18 Jun 2024
- Next filing
- 27 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Robert E. Waltermire filed Form 4 for MADRIGAL PHARMACEUTICALS, INC. (MDGL) on 17 Jan 2025."
What Changed
- Previous filing in this sequence was filed on 18 Jun 2024.
- Current net transaction value: -$120,847.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDGL | Common Stock | Sale | $120,847 | -442 | -8% | $273.41 | 5,058 | 17 Jan 2025 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The sale reported on this Form 4 represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person. |